PRIVATE medical insurance premiums could snowball when cancer drug Herceptin is licensed for use within the NHS, warns a leading consultant.
Most insurers are expected to extend their cover to include the drug treatment – unless specific exclusions are made – although PMI costs will increase by up to £25,000 for each employee treated. ...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
